3D ADEPT (3DA)’s Post

🚀 Introducing BIORES INX: The Future of Gelatin-Based DLP Bioprinting We’re proud to launch BIORES INX, our latest innovation in bioprinting materials! This cutting-edge resin is gelatin methacrylamide (GelMA)-based, offering unmatched biocompatibility and user-friendly features for digital light processing (DLP) bioprinting. Why BIORES INX stands out: ✅ Ready-to-use, sterile, and ISO 10993-5 compliant. ✅ Eliminates common challenges like heating and water evaporation during printing. ✅ Seamlessly integrates with multiple bioprinting platforms for efficiency and scalability. Developed from decades of research at Ghent University, BIORES INX is a testament to our commitment to advancing biofabrication. 📍 Join us at the MRS Fall Meeting (Dec 2–6, Boston) for the official launch. 🛒 Available now via our BIO INX webshop and Carl Roth GmbH + Co. KG Learn more about this innovation here: https://lnkd.in/dTRBQgRX #Bioprinting #Bioinks #GelMA #Biofabrication #TissueEngineering #Innovation #BIOINX #FromLightToLife

I have an open ended question about bioprinting. I am very curious to learn about your thoughts on it so help me out. The question is for both, people directly working with it and people who probably have only heard about bioprinting (3D additive manufacturing using biomaterials with or without living cells). If you are not working directly with bioprinting, what expectations or capabilities pop up in your mind when you hear about the field? And anyone in between. If you are working directly with bioprinting, what were your expectations when you started. Has it met your expectations and what are the challenges that you are facing and trying to solve now? Also, if you have any questions, this is a good opportunity so don’t be shy. There are no wrong or silly questions. #opendiscussion #bioprinting #bioink #additivemanufacturing #3D #2D #tissueengineering #regenerativemedicine #industry

New research article out from the Craig E. Banks group within the Electrochemistry and Polymer research labs at The Manchester Metropolitan University. Published in a special edition entitled New Horizons in 3D Printing Applications within the Elsevier journal Applied Materials Today (IF = 8.3). Within this work we produce a highly conductive filament from recycled PETg which can be sterilised without affecting the electrochemical performance, opening up the possibility of reliable and high-performance 3D printed healthcare sensors. We achieved this by incorporating carbon black, multi-walled carbon nanotubes and graphene nanoplatelets into recycled PETg. Our material shows no decrease in electrochemical performance after sterilisation, unlike a commercial PLA benchmark. We then applied this toward the detection of useful analytes within healthcare. The research was brilliantly performed by our visitor Jessica Camargo from Bruno Janegitz group in Brazil, led by Elena Bernalte Morgado, and supported by James Redfern and Alex Cunliffe. This work highlights how the Electrochemistry and Polymer Research Laboratories at MMU collaborate both cross-departmentally within the University and Internationally. #research #additivemanufacturing #3Dprinting #healthcare #sensors #electrochemistry Please check out the work below: https://lnkd.in/emRVjps5

Revolutionising the field of bioprinting with these bioinks. BIO INX collaborates with Readily3D to introduce new biomaterials for volumetric 3D bioprinting. The first commercially available bioink is a state-of-the-art, gel-MA-based ink, dubbed READYGEL INX and designed for high reproducibility and unparalleled performance in volumetric bioprinting applications. Jasper Van Hoorick, CEO of BIO INX shared that “this collaboration perfectly aligns with our vision of bringing bioprinting technology to clinics within the next decade. Prioritizing standardization, reproducibility, and ‘turn-key’ bioprinting solutions, volumetric bioprinting marks a substantial advancement toward achieving these goals.” #3dprinting #bioprinting #bioinks #volumetricbioprinting #additivemanufacturing #biomaterials

Belgian firm BIO INX has released a new vat polymerization DLP resin for bioprinting, derived from gelatin methacrylamide (Gel-MA) and naturally sourced from collagen. The resin was developed by Ghent University and is highly biocompatible and easy to process, but a little expensive. Joris Peels reports.

Belgian firm BIO INX has released a new vat polymerization DLP resin for bioprinting, derived from gelatin methacrylamide (Gel-MA) and naturally sourced from collagen. The resin was developed by Ghent University and is highly biocompatible and easy to process, but a little expensive. Joris Peels reports.

The research focuses on developing photocurable liquid formulations using renewable resources like terpenes and itaconic acid, aiming to replace petroleum-based materials. A biobased resin, perillyl itaconate (PerIt), was synthesized from renewable sources and used to create networks with adjustable properties through photoirradiation. By adding nonmodified terpenes as reactive diluents, a wide range of photocured networks was produced with varying mechanical properties. The resins showed rapid curing kinetics, could form brittle or elastic materials, and displayed good thermal resistance. Selected formulations, particularly those containing PerIt and limonene, were suitable for additive manufacturing, allowing for high-resolution object printing using digital light processing (DLP). Overall, this method offers a straightforward approach to prepare renewable resins for rapid prototyping applications. Read more details: https://lnkd.in/eTFSfRfB #polymerscience #additivemanufacturing

Belgian firm BIO INX has released a new vat polymerization DLP resin for bioprinting, derived from gelatin methacrylamide (Gel-MA) and naturally sourced from collagen. The resin was developed by Ghent University and is highly biocompatible and easy to process, but a little expensive. Joris Peels reports.

3D bioprinting technology is widely used by researchers to fabricate tissue or organ constructs through combining #biomaterials and living cells for #tissueengineering and #regenerativemedicine applications. As #bioprinting continues to advance, researchers are now investigating suitable biomaterial ink formulas that simulate the extracellular matrix (#ECM) to further develop #bioinks for bioprinting in-vitro #tissuemodels. This review discusses some of the challenges and considerations to assist researchers in identifying biomaterial inks for extrusion-based 3D bioprinting: https://lnkd.in/g_ZPP3gs #3dprinting #biocompatibility #biofabrication 

Very nice work. Biocatalysis is an important field in pharmaceutical Development.